Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 737.82 million compared to CNY 797.64 million a year ago. Net loss was CNY 140.25 million compared to net income of CNY 50.33 million a year ago.

Basic loss per share from continuing operations was CNY 0.3962 compared to basic earnings per share from continuing operations of CNY 0.1433 a year ago. Diluted loss per share from continuing operations was CNY 0.3942 compared to diluted earnings per share from continuing operations of CNY 0.1427 a year ago.